Search results
Results From The WOW.Com Content Network
Plasmodium berghei is a single-celled parasite causing rodent malaria.It is in the Plasmodium subgenus Vinckeia.. Originally, isolated from thicket rats in Central Africa, P. berghei is one of four Plasmodium species that have been described in African murine rodents, the others being P. chabaudi, P. vinckei, and P. yoelii.
In 1880, Alphonse Laveran discovered that the causative agent of malaria is a parasite. [2] Detailed work of Golgi in 1886 demonstrated that in some patients there was a relationship between the 72-hour life cycle of the parasite and the chill and fever patterns in the patient. [2] The same observation was found for parasites with 48-hour ...
The major areas of research carried out over the years are on mosquito fauna surveys, development of genetic and molecular markers for important malaria vectors and parasites, cytotaxonomic studies identifying major vectors as species complexes and laboratory and field studies to examine the biological variations among sibling species ...
In 2000, 1.7 million (1.8%) African children living in areas of the world where malaria is common were protected by an ITN. That number increased to 20.3 million (18.5%) African children using ITNs in 2007, leaving 89.6 million children unprotected [ 95 ] and to 68% African children using mosquito nets in 2015. [ 96 ]
In 2000, 1.7 million (1.8%) African children living in stable malaria-endemic conditions were protected by an ITN. That number increased to 20.3 million (18.5%) African children using ITNs in 2007, leaving 89.6 million children unprotected. [ 54 ]
The logo of the Drugs for Neglected Diseases initiative (DNDi) The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness (human African trypanosomiasis, HAT), Chagas disease, [1] malaria, filarial ...
Video recording of a set of presentations given in 2010 about humanity's efforts towards malaria eradication. The eradication of infectious diseases is the reduction of the prevalence of an infectious disease in the global host population to zero. [1] Two infectious diseases have successfully been eradicated: smallpox in humans, and rinderpest ...
RTS,S/AS01 (brand name Mosquirix) [1] is the first malaria vaccine approved for public use. It requires at least three doses in infants by age 2, with a fourth dose extending the protection for another 1–2 years. [4] The vaccine reduces hospital admissions from severe malaria by around 30%. [4]